Elevated expression of human nonpancreatic phospholipase A2 in psoriatic tissue
- 1 February 1994
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 18 (1) , 1-12
- https://doi.org/10.1007/bf01534593
Abstract
In involved psoriatic tissue, which is characterized by chronic inflammation in both epidermis and dermis, elevated levels of arachidonic acid and eicosanoids have been measured. This implies that a phospholipase A2 (PLA2) may be involved in the pathogenesis of psoriasis. The PLA2's are a group of enzymes that release unsaturated fatty acids from thesn2-position of membrane phospholipids. Once released, the fatty acids are converted by various enzymes into biologically very important signaling molecules. Release of arachidonate initiates the arachidonate cascade, leading to the synthesis of eicosanoids such as prostaglandins, thromboxanes, leukotrienes, and lipoxines. Eicosanoids are important in a variety of physiological processes and play a central role in inflammatory reactions and in intracellular signal transduction processes. Other important inflammatory mediators, such as lyso-PAF (a precursor for PAF) and other lysophospholipids, may also be formed through the action of a PLA2. We report for the first time the detection of transcripts of nonpancreatic phospholipase A2 (npPLA2, type II) and cytosolic (c) PLA2 in human skin, and overexpression of npPLA2 in involved skin from patients with psoriasis (plaque psoriasis and pustular psoriasis). Limited amounts of npPLA2 enzyme are detected immunologically in the uppermost layers of epidermis from healthy persons. Both involved and uninvolved psoriatic epidermis contain higher levels of npPLA2 than normal skin. Positive cells in dermis showed significantly higher levels of npPLA2 than epidermal cells. In dermis from healthy persons, only weak staining of a few cells could be detected. The two PLA2 enzymes detected in psoriatic skin (cytosolic and nonpancreatic) may both be involved in eicosanoid overproduction in psoriatic tissue, and the npPLA2 may also be involved in potentiating cell activation, especially T cells.Keywords
This publication has 29 references indexed in Scilit:
- Expression, purofocation and biochemical comparison of natural and recombinant human non-pancreatic phospholipase A2Biochemical and Biophysical Research Communications, 1992
- Transforming growth factors type‐β and dexamethasone attenuate group II phospholipase A2 gene expression by interleukin‐1 and forskolin in rat mesangial cellsFEBS Letters, 1992
- Eicosanoid generation from antigen‐primed mast cells by extracellular mammalian 14‐kDa group II phospholipase A2FEBS Letters, 1991
- Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 Å resolutionNature, 1991
- Comparison of Eicosanoid Generation by Highly Purified Human Langerhans Cells and KeratinocytesJournal of Investigative Dermatology, 1990
- Bacterial phospholipid hydrolysis enhances the destruction of Escherichia coli ingested by rabbit neutrophils. Role of cellular and extracellular phospholipases.Journal of Clinical Investigation, 1990
- A Unique Phospholipase A2 in Human Epidermis: Its Physiologic Function and Its Level in Certain DermatosesJournal of Investigative Dermatology, 1988
- Inflammatory Effect of Intradermal Administration of Soluble Phospholipase A2 in RabbitsJournal of Investigative Dermatology, 1986
- Characterization of lipoxygenase metabolites of arachidonic acid in cultured human skin fibroblastsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979